— Know what they know.
Not Investment Advice
Also trades as: BTMDW (OTC) · $vol 0M

BTMD NASDAQ

biote Corp.
1W: -5.7% 1M: -31.9% 3M: -49.6% YTD: -53.4% 1Y: -61.4% 3Y: -78.6% 5Y: -88.1%
$1.15
-0.01 (-0.86%)
 
Weekly Expected Move ±6.9%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Medical - Care Facilities · Tech Score Strong Sell · Power 34 · $50.7M mcap · 40M float · 0.684% daily turnover · Short 57% of daily vol
Smart Money Score
Moderate 50
Insider+$0.2M
Congress—
ETF Holdings—
Key Statistics
Market Cap$50.7M
52W Range1.15-3.26
Volume125,332
Avg Volume274,780
Beta1.61
Dividend—
Analyst Ratings
6 Buy 1 Hold 0 Sell
Consensus Buy
Company Info
CEORobert C. Peterson
Employees223
SectorHealthcare
IndustryMedical - Care Facilities
IPO Date2021-04-28
Websitebiote.com
1875 West Walnut Hill Lane
Irving, TX 75038
US
844-604-1246
About biote Corp.

Biote Corp. is dedicated to supporting and developing medical practices that focus on hormone optimization. The company provides a comprehensive system for its Biote-certified healthcare professionals, enabling them to correct imbalances in patients' hormone, vitamin, and mineral levels. This includes authorizing the prescription of bioidentical hormone treatments and suggesting suitable dietary supplements. Furthermore, Biote offers its own line of branded nutritional supplements and supplies sterile kits for inserting hormone pellets for both male and female individuals. Founded in 2011, Biote Corp. is based in Irvine, Texas.

Recent Insider Trades

NameTypeSharesPriceDate
Beer Marc D P-Purchase 16,000 $1.55 2026-08-11
Beer Marc D P-Purchase 115,950 $1.53 2026-08-10
Peterson Robert Char A-Award 206,746 $2.46 2026-06-12
Christensen Bret A-Award 130,000 $2.34 2026-06-08
Beer Marc D A-Award 114,157 $2.34 2026-06-08

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms